Walmart has agreed to pay $50 million to settle a civil lawsuit brought by the U.S. Department of Justice over allegations that the retail company improperly filled prescription opioids across its nationwide pharmacy network.
Settlement Details and Terms
The agreement resolves federal claims against Walmart following a lengthy legal action. The lawsuit filed by the U.S. government had originally sought billions of dollars in financial penalties, accusing the company of failing to properly filter out invalid or unlawful prescriptions for prescription painkillers.
Under the terms of the settlement, Walmart will pay $50 million to conclude the federal litigation, avoiding further prolonged court proceedings over its past prescription fulfillment practices.
Background of the Allegations
Federal prosecutors alleged that Walmart pharmacists filled invalid prescriptions for controlled substances, contributing to the broader prescription drug crisis in the United States. The government asserted that the company’s internal controls were insufficient to prevent suspicious orders from being distributed and dispensed.
The agreement marks the resolution of the federal government’s specific enforcement case against Walmart regarding opioid distribution and pharmacy operations.
